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Abstract
Background: There are few research tools in Brazil to assess more broadly the alcohol and other 
drug related problems. Objective: To test the psychometric properties of ASI in its sixth version 
(ASI-6). Methods: A multicenter cross-sectional study was conducted in four Brazilian state capitals. 
Four research centers interviewed 150 adult inpatients or outpatients, and one research center 
interviewed 140 patients. A total of 740 substance abusers were selected. Training and supervision 
of interviewers were performed to assure the quality of dada collected. Results: Most areas of 
the ASI showed good reliability between the instrument and the interviewers, with no statistically 
significant differences between the ASI-6 Summary Scores for Recent Functioning (SS-Rs) of both 
interviews. Cronbach’s alpha for ASI-6 subscales ranged from 0.64 to 0.95. Correlations between 
the ASI-6 Alcohol and Drug scores and the concurrent instrument (ASSIST) were high (0.72 and 
0.89, respectively). There was a significant negative correlation between the scores in psychiatric, 
medical and drug areas and the scores of WHOQOL. Conclusion: Analysis of the psychometric 
properties of ASI-6 both in outpatients and inpatients in Brazil indicate a good reliability and 
validity of this instrument for the Brazilian culture. The development of this instrument in Brazil 
is an important advancement, which will certainly have implications for the prevention, clinical 
research, and social rehabilitation fields. 
©2012 Elsevier Editora Ltda. All rights reserved.
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Propriedades psicométricas da sexta versão da Escala de Gravidade de Dependência 
(ASI-6) no Brasil
Resumo
Introdução: Existem poucos instrumentos de pesquisa no Brasil que avaliam de forma mais ampla os 
problemas relacionados ao álcool e a outras drogas. Objetivo: Testar as propriedades psicométricas 
da ASI, em sua sexta versão (ASI-6). Métodos: Um estudo transversal e multicêntrico foi conduzido 
em quatro capitais de estados brasileiros. Quatro centros de pesquisa entrevistaram 150 pacientes 
adultos internados ou em tratamento ambulatorial. Foram selecionados um total de 740 abusadores 
de substâncias. A qualidade dos dados coletados foi assegurada pelo treinamento e supervisão 
aos entrevistadores. Resultados: A maioria das áreas da ASI mostraram boa confiabilidade entre 
o instrumento e os entrevistadores, sem diferenças estatisticamente significativas entre os 
Escores Sumários de Funcionamento Recente da ASI-6. O alfa de Cronbach para as subescalas 
da ASI-6 variou de 0,64 a 0,95. Correlações entre os escores da área Álcool e Drogas da ASI-6 
e o instrumento concorrente (ASSIST) foram altas (0,72 e 0,89, respectivamente). Existiu uma 
correlação negativa estatisticamente significativa entre os escores nas áreas psiquiátrica, médica 
e drogas, e os escores da WHOQOL. Conclusão: A análise das propriedades psicométricas da ASI-6 
tanto em sujeitos internados quanto em tratamento ambulatorial no Brasil apontam para uma 
boa confiabilidade e validade deste instrumento para a cultura brasileira.
©2012 Elsevier Editora Ltda. Todos os direitos reservados.
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Introduction
The burden of alcohol and other drug problems on the public 
health system is heavy. However, the relevance of substance 
abuse problems in Brazil has not been paralleled by the 
availability of research in this area. Lack of standardized 
methods for evaluation and treatment of substance abuse 
or dependence may be due to the paucity of instruments 
tailored for the Brazilian culture that ascertain the severity of 
the problems associated with substance use in the country.1,2
Transcultural adaptation and validation of an instrument 
demands careful methodological steps and must consider lo-
cal, social, and cultural aspects.3 This endeavor is particularly 
challenging in Brazil, where multicenter studies of substance 
users face the tasks of dealing with the country’s large ter-
ritorial size, internal cultural diversity, and the characteris-
tics of substance-abusing populations, which are specific to 
the different regional areas.4-8 Substance use disorders are 
particularly susceptible to cultural variation, which makes 
the validation process even more complex.9
Another point of concern is that the chosen evalua-
tion instrument must be objective, clinically useful, and 
encompass a broad timeframe for the target population. It 
also must have easy rules for training in order to diminish 
costs for its implementation. Thus, there is a need for more 
comprehensive instruments with dimensional scores and good 
reliability to be used with substance users both for assess-
ment and follow-up.
The ASI, developed by McLellan and coworkers10 at the 
University of Pennsylvania has already been translated into 
many languages and validated in countries, such as France, 
Italy, Spain, Netherlands, Germany, Russia, Hungary, and 
Japan. It has been used by addiction specialists and clinicians, 
investigators, and policy makers to evaluate the severity of 
alcohol and drug dependence, intervention referrals, and 
treatment results.11-16 The ASI is a semi-structured interview 
that provides a multidimensional assessment of a patient’s 
lifetime and recent status in seven functional areas of life 
(e.g., medical, employment, legal aspects, family/social, 
psychiatric, alcohol use, and other drug use). It estimates 
problem severity in each area; therefore, making it use-
ful for clinical evaluation and investigation. Given these 
advantages, the instrument may be utilized in longitudinal 
studies of treatment outcome.17 It may also help to correct 
therapeutic directions, establishing lines of priority action.
The existing 5th edition of the ASI (ASI-5) has only under-
gone relatively minor revisions, since the original ASI was de-
veloped approximately 25 years ago.10,16 Nevertheless, there 
has been increasing recognition over the years of a number 
of limitations to the ASI, yielding reasons for the instrument 
modification.18 Also, in the last three decades, there have 
been profound changes in the nature of the psychoactive 
substances available, as well as in the characteristics of both 
patient and treatment. Thus, over the past several years, the 
authors of the original instrument have undertaken a major 
revision of the instrument for the sixth version of the ASI. 
Items with poor reliability in the ASI-5 have been deleted 
or refined and others were included (e.g., use of free time, 
trauma, child burden, HIV, smoking, gambling etc.). The ASI-
6 obtains considerably more information than the ASI5, but 
takes no longer to administer. Most items of the ASI-6 are 
more structured than the ASI5, which facilitates training. It 
has added a 6-month time frame for key items, especially 
those relevant to cost analysis, and a date of last occur-
rence probe for key items, especially those items related to 
critical clinical decisions. These timeframes were selectively 
employed in addition to the standard ASI 30-day and lifetime 
intervals. One change in the sixth version was the elimination 
of the Interviewer Severity Ratings, subjective global ratings 
which had variations in reliability. Another point is that ASI-5 
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arithmetically calculated seven Composite Scores to assess 
recent (past 30 day) functioning while in the ASI-6 there are 
2 more problem areas calculated by the new Summary Scores 
for Recent Functioning (SS-Rs).
There are considerable data supporting the validity of the 
ASI recent status scores. This present version has undergone 
final reliability and validity testing and latent structure 
analyses have been conducted. ASI-6 summary measures for 
historical functioning are being developed.16
The fifth version of the instrument was used in Brazil in 
the 1990s to evaluate patients in treatment. However, the 
sixth version modification and its formal validation have 
not been undertaken yet. The Brazilian ASI-6 has already 
been translated and adapted to Brazilian Portuguese and 
involved efforts by investigators from many Brazilian regions. 
Other details of the adaptation process are documented 
elsewhereI.19
In this study, the sixth version of the Addiction Severity 
Index (ASI-6) was submitted to its validation process in Brazil. 
Adaptation and validation to other Portuguese-speaking coun-
tries contexts will still be necessary, but the present work is 
the first step to make it available to the nearly 250 million 
Portuguese-speaking people around the world. The main aims 
of this study were to test the reliability, test-retest, and 
the concurrent validity of the ASI-6 in the Brazilian context, 
demonstrating and discussing the instrument’s psychometric 
properties.
Methods 
Research centers and data collection sites 
This was a multisite, cross-sectional study. The sample was 
collected in five research centers located in four Brazilian 
state capitals. These centers were strategically chosen due 
to their ability to conduct large studies in this area:
• The Center for Drug and Alcohol Research (CPAD) of the 
Universidade Federal do Rio Grande do Sul (UFRGS) was 
the coordinating site for this study. CPAD is located inside 
the Hospital de Clinicas of Porto Alegre, a large teaching 
hospital connected with UFRGS, which has inpatient and 
outpatient services for alcohol and drug problems.
• The Drug Dependence Unit (UDED) is a section of the 
Department of Psychobiology of the Federal Universidade 
de São Paulo. It has an outpatient clinic for those with 
alcohol and drug abuse/dependence as well as their 
families, and is constituted by a multidisciplinary staff.
The Women’s Drug Dependent Treatment Center 
(PROMUD) is located at the Psychiatric Institute of 
Hospital das Clínicas, the largest Brazilian teaching hos-
pital, which is connected with the Universidade de São 
Paulo Medical School. PROMUD is a women-only treatment 
program, and provides mainly outpatient multidisci-
plinary services for alcohol and drug dependent patients.
• The Research Program and Assistance in Drug Addiction 
(PROJAD) develops research activities and services in the 
field of problems related to drug and alcohol abuse on 
an outpatient basis, in connection with the Universidade 
Federal do Rio de Janeiro.
• The Center for Drug Abuse Studies and Therapy (CETAD) 
is a permanent extension of the Department of Pathology 
at the Universidade Federal da Bahia. Its outpatient clinic 
is responsible for psychiatric and psychosocial care of 
drug users and their families.
Sampling 
Between January and November 2006, a target sample of 
740 subjects — either under assessment or already under 
inpatient (first 15 days after admission) or outpatient (first 
10 days) treatment for substance abuse or dependence — 
was obtained. There were 150 subjects at each study site, 
except for CETAD, which could not reach the data collection 
goal during the programmed period and evaluated only 140 
patients. Clients were included in the study if they sought 
medical assistance for alcohol and drug problems and had 
been using at least one of these substances in the 30 days 
prior to the interview. Exclusion criteria were neurological 
or severe psychiatric illness with symptoms at the moment of 
the interview. These parameters were clinically determined 
by trained interviewers. They did not use any standard in-
strument for this purpose. Regarding data collection in all 
centers, seven patients were not included in the sample due 
to severe depressive or psychotic symptoms and four patients 
refused to participate in the study. The strategy of including 
patients from both inpatient and outpatient programs was 
specifically intended to generate a sample with character-
istics similar to that of the typical Brazilian population who 
seek specialized alcohol and drug treatment.
Instruments 
The ASI-6 is a multidimensional semi-structured interview, 
which takes between 45 to 90 minutes to be completed and 
must be administered by a trained interviewer. The instru-
ment comprises information in seven areas of life function-
ing, which are as follows: medical, employment status, legal 
aspects, family/social, psychiatric, use of alcohol, and use 
of other drugs. In each area, the symptoms/problems are 
evaluated during the patient’s lifetime, the six previous 
months and specifically in the 30 days that preceded the 
evaluation. Currently, there is one set of summary scores 
available, the ASI-6 Summary Scores for Recent Functioning 
(SS-Rs). The SS-Rs refer to status/functioning in the past 30 
days, and provides objective information derived from items 
based on a combination of rational and empirical methods. 
They are psychometrically derived using nonparametric 
item response theory (NIRT) and classical psychometric 
methods and are standardized, which has the advantage 
of reducing the extent of skewness in the scores. There is 
one score in each problem area, except for family/social in 
which there are 3 different scores: family/social problems, 
family/social support, and child problems. They represent 
standardized T-scores with a mean of 50 and a SD of 10, 
theoretically ranging from 0-100. Higher scores indicate 
greater problem severity.
Concurrent Validity: each study site was responsible 
for collecting ASI-6 data on 100 subjects besides three 
other additional instruments in order to compare them 
I The Brazilian Portuguese version of the ASI6, its manual and a training 
video are available online at the Brazilian Observatory for Drug Information 
-OBID (www.obid.senad.gov.br) and (www.cpad.org.br). They are downloadable 
for free.
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with ASI-6 scores in each area (except for the legal areaII), 
thus generating data for concurrent validation analyses. 
This method was aimed at reducing interview time and 
expenses after calculating the power for each validation 
analysis. Instruments that had been previously validated 
for the Brazilian culture were selected according to their 
psychometric properties and capacity to provide individual 
and global estimates in each specific area, generating 
scores that could be compared to the SS-Rs of the ASI-6. 
• The WHO Quality of Life-BREF (WHOQOL-BREF): a short 
version of the World Health Organization Quality of Life 
(QOL) assessment instrument that is a widely used self-
report instrument to measure QOL. It comprises 26 items, 
which measure the following broad domains: a) physical 
health (pain, medication, energy, mobility, sleep, work); 
b) psychological health (positive feelings, spirituality, 
think, body, esteem, negative feelings); c) social rela-
tionships (relationships, sex, support); and environment 
(safety, finances, information, leisure, home, services, 
transport). It was developed simultaneously in 15 inter-
national centers and validated in Brazilian Portuguese, 
proven to be useful for QOL evaluation and a satisfac-
tory performance concerning all domains for internal 
consistency (Cronbach’s alpha of 0.77) and test-retest 
reliability (coefficients > 0.69).20
• The Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST): this instrument was developed 
by a team of investigators supported by the World Health 
Organization to detect substance use and abuse and was 
validated for Brazilian Portuguese. It shows high sensitiv-
ity and specificity in the detection of alcohol, cannabis, 
and cocaine abuse/dependence and good reliability 
(Cronbach’s alpha of 0.80 for alcohol, 0.79 for cannabis, 
and 0.81 for cocaine).21
• The Social Adjustment Scale-Self Report (SAS-SR): the 
scale is a 54-item questionnaire comprised by of 2 do-
mains, social and work-related functioning, with a 5-point 
response scale ranging from 1 (most positive) to 5 (most 
negative). The Brazilian validation of the instrument 
showed good internal consistency (Cronbach’s alpha of 
0.85). Higher scores on this instrument indicate poorer 
functioning.22
Interviewers
The 25 interviewers were either psychologists or psychia-
trists. The selection of interviewers was done based on the 
candidate’s abilities in multiple areas, including: a) experi-
ence in dealing with sensitive questions, such as drug use and 
its consequences; b) comprehension of research principles 
and experience in obtaining informed consent; and c) inter-
est in the objectives of the study.
Training
The Principal Investigator (PI; FK) was trained by the original 
authors of the ASI-6.16 After completion of on-site training in 
Philadelphia, the standard ASI training and its manual were 
adapted for the 6th versionIII.19 Co-Principal Investigators (Co-PIs) 
were trained in Brazil by the original authors and by the PI. Each 
Co-PI trained his site group, providing an overview of the instru-
ment and general interviewing guidelines, as well as coding 
rules as they apply to the ASI-6. This was followed by a detailed 
section-by-section and item-by-item review of the instrument, 
according to the manual. Interview observation was conducted 
as part of the training. After these procedures, interviewers 
achieved a 90% response rate in a 30-question quiz about the 
ASI in order to be hired. In the final training section, the study 
PI conducted in loco visits at all centers in order to supervise 
and check the interviews in a pilot study. Two interviews were 
video-taped in order to be used for future training, in addition 
to the manual. Following training, interviewers independently 
conducted all interviews at their treatment site.
Logistics and quality control
The quality of the data collected was ensured mainly through 
training, on-site supervision, and support to field interviewers 
provided by the research center coordinators. Throughout 
the entire process of data collection, each study site had a 
weekly meeting to oversee data collection processes, as well 
as to solve logistical problems. After data collection, each site 
was responsible for sending the original questionnaires to the 
coordinating site in Porto Alegre, where all data were entered 
into a single database by two junior statisticians. On a weekly 
basis, the PI called or e-mailed the Co-PIs in order to discuss the 
flow of cases and to solve problems related to data collection.
Test-retest
A random subsample of 51 patients was asked to repeat the 
initial interview using the ASI-6 with a different data collector 
in a period ranging from three to seven days after the first 
interview, in order to ascertain the instrument’s test-retest 
reliability. They had the summary scores compared to cal-
culate inter-rater reliability.
Inter-rater reliability
Although other studies in the literature suggest the use of 
videos in order to test inter-rater reliability,12 we decided not 
to use the taped ASI interviews. Because this instrument is a 
semi-structured interview, we were interested in measuring 
the scores in a situation where interviewers would be blind to 
the questions and answers of other interviewers. Therefore, 
we compared the scores of 41 random pairs of interviewers 
from all centers. They applied the questionnaires separately 
to the same patient (41 patients).
Procedures and analyses
Data were analyzed using version SPSS v.14.0. A statistician 
was responsible for checking data entry and performing qual-
ity checks. The characteristics of the sample were described 
with means and standard deviation when the variable was 
symmetrical and quantitative and by median and interquar-
tile range when asymmetric. Qualitative variables were 
described in percentages. Quantitative variables were com-
pared using Analyses of Variance (ANOVA), followed by Tukey’s 
test; categorical variables were analyzed by Chi-square test 
II Another study among prisoners is being conducted in order to validate the 
legal area.
III Available at www.cpad.org.br or upon request to the authors
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and multiple comparisons. Internal consistency of the ASI-6 
SS-Rs was evaluated using Cronbach´s alpha. Convergent and 
discriminant validity were evaluated by Pearson’s correlation 
coefficient between items and scores, as well as within and 
across sections. In order to evaluate the agreement between 
judges, we used a paired t-test, Bland and Altman’s method 
and intraclass coefficient correlation and the stability of 
measures over time with the same analyses. The significance 
level was set at 5% for all analyses.
Ethics and reimbursement
The study was approved by the Institutional Review Board 
(IRB) of Hospital de Clínicas of Porto Alegre and by the re-
spective IRBs of each study site. All participants underwent 
approved informed consent procedures. Patients received 
the equivalent of U$15 for each interview as compensation 
for their costs of food and transportation.
Results
The overall sample (n = 740) is summarized in Table 1, and 
consisted mostly of Caucasian males in their thirties, not 
living with a partner. Most participants also had not finished 
high school and had no regular job. Other findings that were 
not included in this table showed that most subjects (81%) 
reported using alcohol in the 30 days prior to the interview, 
while 51% used cocaine/crack, followed by marijuana (41%), 
sedatives (27%), and stimulants (4%). Cocaine (44%) and alco-
hol (43%) were considered the main drugs that led patients 
to seek treatment.
Test-retest reliability measures showed no significant 
differences between summary scores of both interviews, 
except for the employment area, as reported in Table 2. 
The differences between groups means were also calculated 
according to treatment setting and there were no statisti-
cal significances in the inpatient group, while significant 
differences was found in the outpatient group with regard 
to employment subscale (p = 0.008 and effect size = 0.61) 
and family/social support (0.038 and effect size 0.43). The 
limits of agreement show that the two evaluations agree 
in most areas. Generally, variations are not higher than 10 
points in SS-Rs (CI = 95%), which is lower than most standard 
deviations of each ASI-6 sub-area. We can observe that most 
correlations are also strong, especially between interviews 
related to alcohol and drug areas.
Inter-rater comparisons also demonstrated similar scores 
between interviewers in all areas of the ASI, except for 
employment and alcohol (Table 3). The effect size for the 
differences between groups means was moderate (0.75) for 
the employment ASI subscale and it was small (0.43) for the 
alcohol subscale. Similarly to the test-retest, the limits of 
agreement show that the evaluations of the two interview-
ers agree in most areas. Particularly, in the medical area, 
the agreement and correlation were lower than other areas.
Cronbach’s alphas for the ASI-6 subscales ranged from 
0.64 to 0.95, and correlations between these areas ranged 
from 0.09 to 0.40, as may be seen in Table 4. Correlations 
between the ASI-6 Alcohol and Drug scores and the ASSIST 
were high (0.72 and 0.89, respectively). There was a sig-
nificant negative correlation between scores in psychiatric, 
Table 1  Sample characteristics in all centers (n = 740)
Characteristics TOTAL
Male sex (%) 78.0
Mean age (SD)* 36 (12)
Steady partner (%) 34.0
White ethnicity (%) 52.5
Outpatient (%) 60.5
Elementary and High School (%) 70.3
Unemployed (%) 47.4
* Symmetric quantitative variables are described with mean and standard 
deviation. 
Categorical variables are described in absolute frequencies and 
percentages.
Table 2  Test-retest: summary scores (SS-R) of the ASI-6 (three to seven days after initial interview), (n = 51)
ASI subscales Mean SS-R* interview 1 Mean SS-R* interview 2 p-value 95% CI***
 limits of agreement
ICC****
 (CI 95%)
Drug 47.4 (12.4) 47.1(12.5) 0.62 -0.35 (-10.57 to 9.87) 0.92 (0.86 to 0.95)
Family/Child 52.2 (7.5) 51.8 (7.5) 0.25 -0.39 (-5.25 to 4.47) 0.95 (0.91 to 0.97)
Alcohol 58.6 (10.1) 58.5 (9.9) 0.84 -0.08 (-5.68 to 5.52) 0.96 (0.93 to 0.98)
Psychiatric 51.5 (7.8) 51.2 (7.5) 0.60 -0.31 (-8.87 to 8.25) 0.84 (0.74 to 0.91)
Medical 46.0 (8.3) 46.7 (8.5) 0.35 0.68 (-9.46 to 10.82) 0.82 (0.70 to 0.89)
Legal 50.4 (6.5) 50.8 (6.6) 0.47 0.39 (-7.23 to 8.01) 0.83 (0.72 to 0.90)
Employment 44.7 (10.3) 41.6 (7.6)** 0.002 -3.08 (-16.44 to 10.28) 0.73 (0.57 to 0.84)
Family/Social Support 46.3 (10.7) 44.7 (10.3) 0.10 -1.59 (-15.17 to 11.99) 0.79 (0.66 to 0.88)
Family/Social Problem 55.0 (10.7) 55.3 (9.9) 0.71 0.34 (-12.54 to 13.22) 0.89 (0.81 to 0.94)
* Summary scores are described by mean (standard deviation); ** Scores differ significantly from first interview; *** Confidence Interval; **** Intraclass 
coefficient correlation.
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Table 3  Inter-rater reliability: ASI-6 summary scores (SS-R) between interviews (n = 41)
ASI subscales Mean SS-R*
interviewer 1
Mean SS-R* 
interviewer 2
p-value 95% CI***
limits of agreement
ICC**** 
(CI 95%)
Drug 49.3 (10.0) 48.7 (8.2) 0.44 -0.61 -10.51 to 9.29) 0.85 (0.74 to 0.92)
Family/Child 54.4 (9.7) 54.9 (9.8) 0.66 0.46 (-12.94 to 13.86) 0.76 (0.60 to 0.87)
Alcohol 55.5 (9.3) 57.5 (9.3) 0.01 2.0 (-7.28 to 11.28) 0.86 (0.78 to 0.93)
Psychiatric 50.9 (7.8) 49.7 (6.8) 0.21 -1.20 (-13.18 to 10.78) 0.67 (0.45 to 0.81)
Medical 47.6 (9.4) 48.5 (8.7) 0.54 0.83 (-16.37 to 18.03) 0.55 (0.29 to 0.73)
Legal 48.4 (6.5) 48.6 (6.1) 0.68 0.20 (-5.86 to 6.26) 0.89 (0.80 to 0.94)
Employment 44.0 (10.4) 40.1 (8.2)** 0.001 -3.90 (-14.32 to 6.52) 0.85 (0.73 to 0.92)
Family/Social Support 45.6 (9.2) 45.3 (8.9) 0.79 -0.29 (-14.33 to 13.75) 0.70 (0.50 to 0.83)
Family/Social Problem 55.7 (8.8) 55.2 (9.8) 0.61 -0.51 (-13.13 to 12.11) 0.87 (0.76 to 0.93)
* Summary scores are described by mean (standard deviation); ** Scores differ significantly from first interview; *** Confidence Interval; **** Intraclass 
coefficient correlation.
Table 4  Internal consistency of ASI-6 subscales and correlation between summary scores (SS-R) of each area (n = 740)
ASI subscales Cronbach’s 
alpha
Drug Family/Child Alcohol Psychiatric Medical Legal Employment Family/ Social 
support
Family/
Social problem
Drug 0.95 1 0.07 - 0.37* 0.29* 0.05 0.37* 0.09* -0.06 0.28*
Family/Child 0.79 1 -0.02 0.15* 0.13* 0.08* -0.004 -0.09* 0.22*
Alcohol 0.93 1 0.15* 0.18* -0.11* -0.03 0.10* -0.04
Psychiatric 0.82 1 0.40* 0.25* 0.17* 0.11* 0.38*
Medical 0.82 1 0.13* 0.10* 0.11* 0.17*
Legal 0.73 1 0.14* -0.02 0.29*
Employment 0.90 1 0.19* 0.06
Family/Social Support 0.81 1 -0.16*
Family/Social Problem 0.64 1
* p < 0.05.
Table 5  Correlations between ASI-6 summary indexes and concurrent validity measures
ASI subscales Score 
ASSISTAlcohol
Score ASSIST 
Drugs**
Whoqol 
Physical
Whoqol 
Psychological
Whoqol Social
Relation
Whoqol 
Environment
SAS
Work
SAS
Leisure
SAS
Family
SAS Finan
ces
Alcohol 0.72* -0.38* -0.16* -0.02 -0,11 0.01 0.06 0.19* -0.05 -0.005
Family/Child -0.07 0.06 -0.25* -0.14 -0.08 -0.23 0.04 -0.04 0.11
Drug -0.39* 0.89* -0.11 -0.38* -0.07 -0.12 0.14* 0.02 0.09 0.22*
Psychiatric 0.11* 0.25* -0.76* -0. 75* -0.43 -0. 67* 0.20* 0.17* 0.22* 0.20*
Medical 0.11* 0.06 -0.41* -0.14 -0.11 -0.14 0.14* 0.21* 0.07 0.07
Legal -0.19* 0.37* 0.35 -0. 09 0.20 0.42 0.17* 0.001 0.20* 0.17*
Employment   -0.03 0.08 -0.31* -0.21* -0.10 -0.32* 0.47* 0.16* 0.20* 0.34*
Family/Social Support 0.09 -0.07 -0.03 -0 .06 -0.07 -0.12* 0.16* 0.47* 0.15* 0.15*
Family/Social Problem -0.02 0.26* -0.16* -0.15* -0.16* 0.10 0.04 -0.01 0.25* 0.14*
*p < 0.05; Pearson correlation coefficients; ASSIST: The Alcohol, Smoking and Substance Involvement Screening Test; WHOQOL: World Health Organization 
Quality of Life-BREF questionnaire; SAS: Social Adjustment Scale.
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medical and drug areas and the WHOQOL scores. The posi-
tive correlation between employment problems and social 
adjustment scores was significant, but moderate. These data 
are summarized in Table 5.
Discussion
To the best of our knowledge, this is the first validation study 
of the Addiction Severity Index in a Latin-American country. 
The classical analyses of the psychometric properties of the 
Brazilian ASI-6 for both inpatient and outpatient subjects 
indicate good reliability and validity of the existing summary 
scores of this instrument for our culture.
Test-retest reliability and inter-rater reliability
We used the summary scores in order to evaluate the psy-
chometric properties of the ASI areas, as has been done in 
the majority of research studies with the ASI.16 The reliability 
of the patient self-report data of the ASI-6 over a three to 
seven day test-retest interval was good, with the exception 
of the employment area. In other areas, paired statistical 
comparisons of the summary score measures showed no 
significant differences (p > 0.10) between the interviews 
conducted by the same technician.
Inter-rater reliability tests found similar results with 
significant differences only in the employment area. Based 
upon the available data, as well as de-briefing and discussions 
with the interviewers, we believe that the variation in re-
sponses to the employment section was due to difficulties 
in asking about finances and recalling exact figures (e.g., 
how much money have you received in the last 6 months?). 
Informality, unstable employment status, and the multiplicity 
of sources of income frequently encountered among alcohol 
and drug abusers may also account for difficulties in remem-
bering and providing reliable information. It seems that the 
information provided by the items in the employment section 
is not always sufficient to achieve reliable ratings of problem 
severity. The level of information in these areas may improve 
by adding more detailed questions, in particular about dura-
tion of unemployment and specific aspects of problems with 
significant others.
We also found a higher disagreement and lower correla-
tion of SS-Rs in the medical area when ASI-6, which points 
to the need of an improvement in training related to the 
medical diagnosis specified in the instrument, is applied 
especially by non medical interviewers.
Concurrent validity measures
Comparisons of ASI subscale scores with a battery of previ-
ously validated tests indicate clear evidence of discriminant 
validity, as discussed by Lowe.23 Most validation studies 
show a moderate correlation between ASI summary scores 
and other instruments.18 For instance, correlations between 
psychiatric problems and the WHOQOL domains would 
be expected. Recently, findings from the American ASI6 
validationIV showed that concurrent validity analyses yielded 
strong evidence supporting the validity of the six of the SS-R 
scores (Medical, Alcohol, Drug, Employment, Family/Social 
Problems, Psychiatric). Evidence was weaker for the Legal, 
Family/Social Support and Child Problems SS-R.
In our study, summary scores of the psychiatric area 
presented good correlation with the physical, psychological 
and environment WHOQOL domains. Many aspects of the ASI 
evaluation are included in the domains of quality of life, 
and it has become more clear that substance abuse and 
other psychiatric comorbidity often lower its scores.24 The 
ASSIST alcohol and drug scores showed high correlations with 
the alcohol and drug ASI sections. This is important, since 
it demonstrates that these essential sections of the sixth 
version are highly reliable. We also found a significant but 
moderate correlation between the employment section and 
the SAS work and financial scores.
While the problem areas represent distinct dimen-
sions on a conceptual level, in real life situations it is 
often difficult to keep them apart. This is especially true 
for the psychiatric scale, because psychiatric symptoms 
may be induced by substance use, as has been robustly 
documented.25-28 In these cases, the judgment of a clini-
cian is needed in order to diagnose the symptomatology 
appropriately.
The quantity and quality of available information from 
the family and psychiatric sections are less detailed than 
the other areas, requiring analysis of specific outcomes. The 
structured format of the ASI and the fixed-choice questions 
seem adequate or better for assessing other problem areas, 
but this format seems less appropriate for the myriad of com-
plex and highly individualized family problems occurring with 
these patients. The psychiatric summary score also should not 
be directly compared with psychiatric diagnoses. However, 
a significant positive correlation was found between ASI-5 
composite scores (CSs) and DSM-IV diagnoses of dependence 
in both the alcohol and drug domains. Results showed good 
to strong prediction: ASI scores identified dependent clients 
with approximately 85% sensitivity and 80% specificity.29 
Therefore, future studies are being planned with the goal of 
comparing ASI scores with other scales as Family Enviroment 
Scale (FES) scores and the Mini International Neuropsychiatric 
Interview (MINI).
Internal consistency and correlation among 
problem areas
In most ASI validation studies, Cronbach’s alpha of sub-
scales is usually between 0.80 and 0.95.16 Despite the 
acceptable scores found in Table 5 that are very similar 
to other studies, data indicate that in some areas, such 
as legal and family/social, the instrument consistency is 
still unstable.30 Our results confirm these findings. A recent 
study that also analyzed the psychometric properties of 
the ASI-6 translated and adapted into the Spanish language 
showed that the degree of the internal consistency of the 
standardized objective scores ranged between 0.85 and 
0.95, except for legal (0.47), family/child (0.58) and fam-
ily/social (0.70) problems.31
Typically, correlation among areas of the ASI is low. Two 
validation studies of the ASI are pointed out among the publica-
tions in this area. Daeppen et al. conducted the first study in 
France.11 In our study, the highest correlation occurred between 
the medical and psychiatric problem areas. The latter was also 
significantly correlated to the legal, employment, and family IV  Cacciola, J. Personal communication
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areas, probably expressing the relevant role of psychiatric 
symptoms in the problems of substance abusers, reinforcing the 
importance of including innovative inpatient dual diagnosis 
treatment programs, especially within the public system.1 
The moderately high correlation between the family/social 
and the psychiatric summary scores may reflect self-selec-
tion, as the study sample consisted only of treatment-seeking 
addicts. As suggested earlier by Rounsaville and Kleber, the deci-
sion to seek treatment is often made during a crisis of a social 
nature, in which individuals may have the tendency to report 
more psychological problems.32 This suggestion is supported by 
earlier findings that show a decrease in psychological symptoms 
soon after admission to treatment.33-35 These findings highlight 
the importance of independent measurement of different 
dimensions of the subject’s functioning (presenting a specific 
problem profile) in order to identify specific treatment needs.
Conclusion
The similarity in psychometric characteristics of the ASI in 
different sociocultural contexts advocates the use of this in-
strument in cross-cultural research. In this study, the internal 
consistency of the Brazilian version of the ASI-6 seems to be 
high and correlations among areas were low, corroborating 
other studies in the literature. With regard to test-retest reli-
ability, the results were similar to other studies that portrait 
the ASI as a stable instrument, as its scores do not vary much 
in a short period of time. The moderate correlation between 
scores of each problem area with assessments on concurrent 
validity also confirms the validity of the ASI-6 construct. The 
subscales also demonstrated to be relatively independent, and 
the severity ratings showed good concurrent validity; they also 
could be predicted, to a large extent, by the scale items. In 
addition, the subscales showed evidence of reliability. These 
findings add to the results from American and European studies 
that indicate good reliability and validity of the instrument. 
In particular, further research is needed on discriminant and 
predictive validity of the Brazilian version of ASI.
The authors are aware of some limitations. Usually, a 
heterogeneous and diverse sample is recommended for 
validation studies, but the cultural differences of these 
regions from other Brazilian regions were not assessed 
by the study. Moreover, subjects were selected only from 
public clinics and hospitals from state capitals, which may 
jeopardize the generalization of findings. Nevertheless, 
most research production in the country is developed in 
these states and they also represent a very broad spectrum 
of the Brazilian culture and population, especially people 
who live in urban centers. It is also important to mention 
that other modern analysis of structural validity evaluation 
are beyond the scope of this manuscript and the authors 
intend to do it in the future.
It is relevant to mention that there is an immense difficul-
ty with regard to standardized communication among profes-
sionals in the addiction field in Brazil, particularly with regard 
to the comparison of data from clinical settings in the several 
networks that are included by the treatment services.36 Not 
only is the comparison of research findings problematic, but 
also the perspective of being able to use an instrument with 
characteristics that are unanimously acknowledged around 
the world. The use of a powerful instrument such as the ASI is 
essential in the country for the reasons mentioned above, as 
well as the development of further computerized systems of 
information collection that are already available elsewhere, 
aiming at the development of sentinel studies (new drugs, 
new forms of use of drugs already known).37 The validity of 
the ASI application was shown through self-completion over 
the Internet. In this application type, some subjects state a 
reduced sensation of being judged.38 Other studies confirm 
that patients tend to give better information about their 
drug use and psychiatric symptoms when the format of a 
self-administered ASI is used.39 Thus, this is suggested as a 
feasible alternative to the monitoring of client treatment. 
Such an application has shown to be faster in determining 
scores; is more economical; and has less gauging possibility 
(inter-interviewer reliability).40
At this time a number of products have already been 
obtained with the development of the ASI in Brazil, including 
an electronic database, a spreadsheet for data insertion, 
and a collaboration with the validation process in Chile. 
With the validation process of the ASI-6, Brazilian investiga-
tors and clinicians will have a reliable instrument in order 
to document and continuously follow-up the treatment 
procedures that are to be offered for such clients. The 
development of this instrument in Brazil is an important 
advancement, which will certainly have an impact on the 
prevention, clinical research, and social rehabilitation 
fields. In the future, the ASI-6 will certainly be used to 
evaluate substance abuse treatment services and improve 
service quality.
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